Arrien Pharmaceuticals

About:

Arrien Pharmaceuticals is a small molecule-targeted therapeutics drug discovery and development company targeting cell signaling pathways.

Website: http://www.arrienpharma.com

Description:

Arrien Pharmaceuticals is a small molecule targeted therapeutics drug discovery and development company working towards targeting cell signaling pathways - A target class in treating neurodegenerative, Cancer, Inflammatory and Metabolic diseases. The Arrien is applying its proprietary platform to successfully discover a portfolio of uniquely identified pre-clinical stage programs in Parkinson's, Alzheimer's Diseases (PD, AD), Cancer, Rheumatoid Arthritis (RA), Type 2 Diabetes and Obesity diseases.

Total Funding Amount:

$2M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Ansonia, Connecticut, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)arrienpharma.com

Founders:

Rajendra P. Appalaneni

Number of Employees:

1-10

Last Funding Date:

2011-09-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai